These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962 [No Abstract] [Full Text] [Related]
6. [Study progress on the mode of action of praziquantel against schistosomes]. Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900 [TBL] [Abstract][Full Text] [Related]
7. New insight into praziquantel against various developmental stages of schistosomes. Wu W; Wang W; Huang YX Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370 [TBL] [Abstract][Full Text] [Related]
8. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841 [TBL] [Abstract][Full Text] [Related]
9. Schistosomiasis therapeutics: whats in the pipeline? Trainor-Moss S; Mutapi F Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363 [TBL] [Abstract][Full Text] [Related]
10. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637 [TBL] [Abstract][Full Text] [Related]
11. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Doenhoff MJ; Cioli D; Utzinger J Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535 [TBL] [Abstract][Full Text] [Related]
12. The potential of artemether for the control of schistosomiasis. Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781 [TBL] [Abstract][Full Text] [Related]
14. Something old, something new: is praziquantel enough for schistosomiasis control? Secor WE; Montgomery SP Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059 [No Abstract] [Full Text] [Related]
15. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel]. Guo J; Guo JG Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016 [No Abstract] [Full Text] [Related]
16. What is the mechanism of action of praziquantel and how might resistance strike? Cupit PM; Cunningham C Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063 [No Abstract] [Full Text] [Related]
17. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Utzinger J; Xiao S; Keiser J; Chen M; Zheng J; Tanner M Curr Med Chem; 2001 Dec; 8(15):1841-60. PubMed ID: 11772354 [TBL] [Abstract][Full Text] [Related]
18. [Advances in research on antischistosomal drugs]. Qiu SJ; Xia CM Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510 [TBL] [Abstract][Full Text] [Related]
19. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? Bergquist R; Utzinger J; Keiser J Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414 [TBL] [Abstract][Full Text] [Related]
20. Better understanding of anti-schistosomal strategies through microarray analysis. Gobert GN Infect Disord Drug Targets; 2010 Aug; 10(4):251-7. PubMed ID: 20429867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]